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Diseases caused by helminths, called helminthoses, are one of the most serious 
problems in veterinary and human medicine. These diseases are treated by 
anthelmintics but their effectiveness is often not sufficient due to resistance of 
helminths against common anthelmintics. The global anthelmintic resistance 
encouraged the developing of new drugs with a different mode of action. 
Monepantel (MOP) belongs to a new class of anthelmintic drugs known as amino-
acetonitrile derivatives (AADs) that act on the nicotinic acetylcholine receptors. In 
2011, MOP was approved for the treatment of gastrointestinal diseases caused by 
nematodes in the veterinary practice in the Czech Republic. It is produced 
commercially under the trade name Zolvix® (Novartis AG). 
 The aim of this doctoral thesis was to study metabolism and effects of MOP 
and other AADs in order to contribute to the global research in this field. For this 
purpose, adults nematodes Haemonchus contortus (the sensitive strain ISE and the 
resistant strain WR) and its hosts Ovis spp. were used. In this study, metabolites of 
MOP formed in vitro (in ovine hepatocytes), in vivo (in urine and faeces from sheep) 
and ex vivo (in living nematodes) were identified. Furthermore, metabolism of the 
other AADs were also studied in vitro in ovine hepatocytes. Metabolic pathways of 
the MOP and its derivatives were compared with each other and in different model 
systems. In the second part of the doctoral thesis, the modulatory effect of MOP on 
the activity and expression of cytochromes P450 (CYP), main biotransformation 
enzymes, was studied in target species- sheep. Significant inducing effect of MOP on 
the CYP3A24 was detected. Last but not least, the efficacy of MOP and its derivatives 
against lower developmental stages of H. contortus was tested. Current information 
about MOP, available from literary sources and obtained also from our experiments, 
were processed to the review article. 
 The obtained results of this doctoral thesis extend the knowledge about 
AADs, new class of anthelmintic drugs. The information about metabolic pathways, 
CYP induction and efficacy of MOP and its derivatives is very important for the safety 
of therapy and evaluation of risks of drug-resistance development in helminths. It 
may lead to improvement and streamlining of helminthosis treatment.  
 
